膀胱癌膀胱内卡介苗治疗后肾脏肉芽肿FDG活性强烈似恶性肿瘤
本文报道一例膀胱癌患者接受膀胱内卡介苗(BCG)治疗后出现BCG相关肾脏肉芽肿,增强CT示病灶边缘不清并渐进性强化,T2加权像呈低信号,FDG PET/CT及延迟腹部FDG PET/MRI示FDG活性程度不一。作者认为,对接受BCG治疗的膀胱癌患者,BCG相关肾脏肉芽肿应纳入FDG高摄取肾脏病灶的鉴别诊断。
要点
- 膀胱内BCG治疗后可发生BCG相关感染性并发症,包括肾脏肉芽肿。
- BCG相关肾脏肉芽肿在增强CT上可表现为边缘不清、渐进性强化。
- 对BCG治疗后的膀胱癌患者,FDG高摄取肾脏病灶需将BCG相关肉芽肿纳入鉴别诊断。
核心结论
- 作者认为,对接受膀胱内BCG治疗的膀胱癌患者,BCG相关肾脏肉芽肿应纳入FDG高摄取肾脏病灶的鉴别诊断。
研究设计与样本
- 本文为病例报告,描述一例膀胱癌患者接受膀胱内BCG治疗后发生BCG相关肾脏肉芽肿的增强CT、FDG PET/CT及延迟腹部FDG PET/MRI表现。
主要发现
- 肾脏病灶在增强CT上表现为边缘不清并呈渐进性强化。
- 肾脏病灶在T2加权像上呈低信号。
- 肾脏病灶在PET/CT及延迟PET/MRI上FDG活性程度不一。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intravesical bacillus Calmette-Guérin (BCG) therapy is an effective immunotherapy for superficial bladder cancer. BCG-related infectious complications may occur following intravesical BCG instillation. We describe contrast-enhanced CT, FDG PET/CT, and delayed abdominal FDG PET/MRI findings in a case of BCG-related renal granulomas following intravesical BCG therapy for bladder cancer. The renal lesions showed ill-defined margins with progressive enhancement on postcontrast CT, hypointensity on T2-weighted images, and variable FDG activity on both PET/CT and delayed PET/MRI. This case indicates that BCG-related renal granuloma should be included in the differential diagnosis of FDG-avid renal lesions in patients with BCG therapy for bladder cancer.
引用
- Man X, Dong C, Song X, et al. Intense FDG Activity of Renal Granuloma Following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer Mimicking Malignancy. Clin Nucl Med. 2025. PMID: 40263758. doi:10.1097/RLU.0000000000005810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。